Pilot Study of Whole Blood Transfusion for Trauma Brain Injury (TBI)
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Our goal is to perform a pilot, single center study to evaluate the efficacy of whole blood (WB) in subjects with TBI, intracranial hemorrhage, and anemia compared to blood component therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Aug 2024
Shorter than P25 for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 7, 2023
CompletedFirst Posted
Study publicly available on registry
December 28, 2023
CompletedStudy Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedApril 2, 2024
April 1, 2024
1.2 years
December 7, 2023
April 1, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Mortality and Morbidity
The primary outcome for this study would be Glasgow Outcome Coma Scale score at discharge.
Up to 30 days after hospital admission
Secondary Outcomes (1)
Improvement in Coagulopathy
Up to 30 days after hospital admission
Study Arms (2)
Whole Blood Transfusion
EXPERIMENTALTransfusion of whole blood units
Blood Component Transfusion
ACTIVE COMPARATORTransfusion of blood components units
Interventions
The transfusion of blood components units rather than whole blood
Eligibility Criteria
You may qualify if:
- Age 15 years and older
- Head CT with presence of intracranial bleeding
- Required transfusion of whole blood (WB) or red blood cells (RBC)
You may not qualify if:
- Patients with non-survivable injuries (expected to die within 24-hours of injury)
- Fixed and dilated pupils
- Patients requiring a massive transfusion protocol activation
- Receipt of 2 units of WB or RBCs prior to enrollment
- Known prisoners
- Known pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Napolitano L. Cumulative risks of early red blood cell transfusion. J Trauma. 2006 Jun;60(6 Suppl):S26-34. doi: 10.1097/01.ta.0000199979.95789.17. No abstract available.
PMID: 16763477BACKGROUNDTimmons SD. The life-saving properties of blood: mitigating cerebral insult after traumatic brain injury. Neurocrit Care. 2006;5(1):1-3. doi: 10.1385/NCC:5:1:1.
PMID: 16960286BACKGROUNDCorwin HL, Carson JL. Blood transfusion--when is more really less? N Engl J Med. 2007 Apr 19;356(16):1667-9. doi: 10.1056/NEJMe078019. No abstract available.
PMID: 17442910BACKGROUNDReiles E, Van der Linden P. Transfusion trigger in critically ill patients: has the puzzle been completed? Crit Care. 2007;11(3):142. doi: 10.1186/cc5936.
PMID: 17583592BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., F.A.C.S., F.C.C.M.
Study Record Dates
First Submitted
December 7, 2023
First Posted
December 28, 2023
Study Start
August 1, 2024
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
April 2, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share